According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

Published Date: 28 Apr 2023

The use of 5-ARI and prostate cancer (PCa) mortality in one study did not show a statistically significant correlation.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI tool identifies women at high risk of interval breast cancer

2.

Best foot forward—chemo care should include podiatry, say researchers

3.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

4.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

5.

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot